Triazine derivatives, and pharmaceutical compositions comprising

Details Triazine derivatives, and pharmaceutical compositions comprising Triazine derivatives, and pharmaceutical compositions comprising

1984-03-12

1986-04-08

Ford, John M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514236, 514237, 514238, 514239, 514242, 544 49, 544105, 544182, C07D40104, C07D41304, C07D41704, A61K 3153

Patent

active

045813566

ABSTRACT:
New triazine derivatives represented by the formula: ##STR1## wherein R.sup.1 is a 1,2,3,4-tetrahydroquinolyl, 2-oxo-1,2,3,4-tetrahydroquinolyl, 2-oxo-1,2-dihydroquinolyl, indolyl, 2-oxoindolinyl, benzothiazolyl, 2-oxobenzothiazolinyl, 3,4-dihydro-1H-2,1-benzothiazinyl in which the S atom being optionally oxidized, or 3-oxo-2,3-dihydro-4H-1,4-benzoxazinyl, each of which may have one or more substituent(s) selected from lower alkyl, hydroxy(lower)alkyl, lower alkylamino, lower alkanoyl, cyclic lower alkanoyl, lower alkoxy(lower)alkyl, lower alkylamino(lower)alkanoyl, benzyl, benzyloxy(lower)alkyl, lower alkoxycarbonyl(lower)alkyl and 4-(2-hydroxyethyl)piperazin-1-yl-carbonylmethyl;

REFERENCES:
patent: 4347359 (1982-08-01), Farge et al.
patent: 4503054 (1985-03-01), Brown et al.
Jochims et al., Chemische Berichte, vol. 109, pp. 154-167, (1976).
Vinot et al., C. R. Acad., SC. Paris, t. 270, pp. 1042-1044, (1970).
Mustafa et al., Chemical Abstracts, vol. 76, p. 34221g, (1972).
Nakayama et al., Journal of Heterocyclic Chemistry, vol. 18, pp. 631-632, (1981).

Affiliated with

Also associated with

Rating

Triazine derivatives, and pharmaceutical compositions comprising does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazine derivatives, and pharmaceutical compositions comprising, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazine derivatives, and pharmaceutical compositions comprising will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2066320